Authors


Jonathon R. B. Halbesleben, PhD

Latest:

CAH Staff Perceptions of a Clinical Information System Implementation

This study examines staff perceptions of patient care quality and the processes before and after implementation of a comprehensive clinical information system in 7 critical access hospitals.




George Chinhung Linn, MD, PhD

Latest:

Financial Incentives and Use of Cesarean Delivery: Taiwan Birth Data 2003 to 2007

This study explores whether the policies of financial incentives for the demand and supply sides lowered the Cesarean section rate.




Ryan M. Conrad, PhD

Latest:

Do Strict Formularies Replicate Failure for Patients With Schizophrenia?

This study measures the impact of Medicaid formulary restrictions on the rate at which patients who failed on a drug therapy for schizophrenia return to the same therapy.




Thomas M. Maddox, MD, MSc

Latest:

Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.


Mark T. Dransfield, MD

Latest:

Implications of DRG Classification in a Bundled Payment Initiative for COPD

Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.




Peter K. Lindenauer, MD

Latest:

Association Between Length of Stay and Readmission for COPD

Among patients admitted for chronic obstructive pulmonary disease (COPD) at Veterans Affairs hospitals, hospital-level length of stay was not associated with 30-day readmission.


Julie Gazmararian, PhD, MPH

Latest:

Exploring Health Plan Perspectives in Collecting and Using Data on Race, Ethnicity, and Language

In-depth interviews were conducted with 15 health plans to explore why plans collect or forgo race, ethnicity, and language (REL) data collection efforts, and the challenges encountered with collecting and using data for quality improvement.


Fang Xia, PhD

Latest:

Is There a Relationship Between Early Statin Compliance and a Reduction in Healthcare Utilization?

Statin therapy compliance of 80% or higher during the first 2 years of treatment is associated with reduced healthcare resource utilization in the following year.


Jacqueline Vanderpuye-Orgle, PhD

Latest:

Understanding Price Growth in the Market for Targeted Oncology Therapies

The prices of targeted oncology therapies have grown substantially, but revenues have not. This is due in part to large declines in per-drug patient counts.


Kenneth E. Thorpe, PhD

Latest:

Racial Trends in Clinical Preventive Services Use, Chronic Disease Prevalence, and Lack of Insurance Before and After the Affordable Care Act

This paper examines whether the Affordable Care Act reduced the disparities in the use of clinical preventive services, chronic disease prevalence, and the number of uninsured.


Frances B. Maguire, PhD, MPH

Latest:

A Population-Based Assessment of Proton Beam Therapy Utilization in California

This population-based analysis of patients with cancer in California found significant differences in proton beam therapy use by health insurance type, race/ethnicity, and socioeconomic status.






Mashele M. Huschka, BS, RN

Latest:

Preferred Roles in Treatment Decision Making Among Patients With Cancer: A Pooled Analysis of Studies Using the Control Preferences Scale

This pooled analysis assesses preferred roles in treatment decision making, actual roles, and preferred versus actual discordance among 6 studies of patients with cancer.



Amy J. Davidoff, PhD

Latest:

ACA Medicaid Expansion Association With Racial Disparity Reductions in Timely Cancer Treatment

Medicaid expansion was associated with a reduction in the racial disparity in timely treatment of patients with advanced cancer in the United States.




Geoff Gerhardt, MPP

Latest:

HIT Press Club AJMC - Geoff Gerhardt, MPP

Geoff Gerhardt, MPP, House Ways and Means Committee, discusses his paper at the National Press Club


Donna Cryer, JD

Latest:

NASH and Liver Cancer: The New Cancer Headline

The most common primary liver cancer, hepatocellular carcinoma, is driven by fatty liver disease and is among the most prevalent and deadly of cancers driven by obesity. Rising rates of overweight and obesity parallel increased rates of obesogenic cancers, which increased 7% between 2005 and 2014.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo